219 related articles for article (PubMed ID: 37263709)
1. Identification of hub necroptosis-related lncRNAs for prognosis prediction of esophageal carcinoma.
Luo Z; Ding E; Yu L; Wang W; Guo Q; Li X; Wang Y; Li T; Zhang Y; Zhang X
Aging (Albany NY); 2023 Jun; 15(11):4794-4819. PubMed ID: 37263709
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
[TBL] [Abstract][Full Text] [Related]
3. Establishment and Analysis of a Prognostic Model of Autophagy-Related lncRNAs in ESCA.
Chen F; Zhang J; Bai W
Biomed Res Int; 2022; 2022():9265088. PubMed ID: 35928921
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analysis of necroptosis‑related lncRNAs and immune infiltration, and prediction of the prognosis of patients with esophageal carcinoma.
Duan X; Du H; Yuan M; Liu L; Liu R; Shi J
Exp Ther Med; 2023 Jul; 26(1):331. PubMed ID: 37346407
[TBL] [Abstract][Full Text] [Related]
5. Necroptosis-related lncRNA signatures determine prognosis in breast cancer patients.
Zhang Y; Yue Q; Cao F; Li Y; Wei Y
Sci Rep; 2022 Jul; 12(1):11268. PubMed ID: 35787661
[TBL] [Abstract][Full Text] [Related]
6. Developing a novel necroptosis-related signature to evaluate the prognostic and therapeutic characteristics of esophageal cancer.
Chen M; Hua T; Yang L; Li C; Xu S; Zhu J; Zhao T
Am J Transl Res; 2023; 15(8):5425-5445. PubMed ID: 37692951
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a novel signature to predict prognosis and immune characteristics of pancreatic cancer based on necroptosis-related long non-coding RNA.
Xiong Y; Kong X; Fang K; Sun G; Tu S; Wei Y; Ouyang Y; Wan R; Xiao W
Mol Biol Rep; 2023 Sep; 50(9):7405-7419. PubMed ID: 37452900
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M
Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432
[TBL] [Abstract][Full Text] [Related]
9. Differential Analysis of lncRNA, miRNA and mRNA Expression Profiles and the Prognostic Value of lncRNA in Esophageal Cancer.
Liu H; Zhang Q; Lou Q; Zhang X; Cui Y; Wang P; Yang F; Wu F; Wang J; Fan T; Li S
Pathol Oncol Res; 2020 Apr; 26(2):1029-1039. PubMed ID: 30972633
[TBL] [Abstract][Full Text] [Related]
10. Identification of Prognostic Signature of Necroptosis-Related lncRNAs and Molecular Subtypes in Glioma.
Zhang G; Chen R; Zhu L; Ma H; Tang H; Shang C; Wang J; Zhang D; Li Q; Liu J
Comput Math Methods Med; 2022; 2022():3440586. PubMed ID: 36110575
[TBL] [Abstract][Full Text] [Related]
11. A risk signature of necroptosis-related lncRNA to predict prognosis and probe molecular characteristics for male with bladder cancer.
Jin Y; Li J; Tang C; He K; Shan D; Yan S; Deng G
Medicine (Baltimore); 2023 May; 102(18):e33664. PubMed ID: 37145007
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics Analysis of Autophagy-related lncRNAs in Esophageal Carcinoma.
Wu D; Ding Y; Fan J
Comb Chem High Throughput Screen; 2022; 25(8):1374-1384. PubMed ID: 34170806
[TBL] [Abstract][Full Text] [Related]
13. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H
Front Immunol; 2022; 13():916800. PubMed ID: 35860239
[TBL] [Abstract][Full Text] [Related]
14. Necroptosis-related LncRNAs in skin cutaneous melanoma: evaluating prognosis, predicting immunity, and guiding therapy.
Liu J; Luo B; Zhang P; Jiang K; Hou Z; Cao X; Tang J
BMC Cancer; 2023 Aug; 23(1):752. PubMed ID: 37580654
[TBL] [Abstract][Full Text] [Related]
15. Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer.
Liu Y; Hao H; Kang L; Zheng G; Guo X; Li B; Zhao H; Hao H
BMC Gastroenterol; 2022 Jul; 22(1):345. PubMed ID: 35840890
[TBL] [Abstract][Full Text] [Related]
16. A Necroptosis-Related lncRNA-Based Signature to Predict Prognosis and Probe Molecular Characteristics of Stomach Adenocarcinoma.
Luo L; Li L; Liu L; Feng Z; Zeng Q; Shu X; Cao Y; Li Z
Front Genet; 2022; 13():833928. PubMed ID: 35330731
[No Abstract] [Full Text] [Related]
17. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Fan Q; Liu B
Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma.
Zhang W; Cao W; Tong Z; Jin Q; Jiang X; Yang Y; Yao H; Chen G; Gao W; Zhu Y; Zhou S
Front Oncol; 2022; 12():1011000. PubMed ID: 36185274
[TBL] [Abstract][Full Text] [Related]
19. A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer.
He WP; Chen YY; Wu LX; Guo YY; You ZS; Yang GF
Front Immunol; 2022; 13():1018544. PubMed ID: 36466815
[TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status.
Chen C; Wu Y; Chen K; Xia Z; Liu X; Zhang C; Zhao H; Shen A
Front Genet; 2022; 13():898507. PubMed ID: 35754846
[No Abstract] [Full Text] [Related]
[Next] [New Search]
